Sat 28 Nov 2009 | 14:38 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Cytokinetics, Incorporated

Cytokinetics, Incorporated (CYTK.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View CYTK on other exchanges
As of  27 Nov 2009
3.25USD
Price Change
-0.10
Percent Change
-2.99%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Cragg, David 53 2005 Vice President - Human Resources
Trautman, Jay 50 2007 Vice President - Discovery Research & Technology
Wolff, Andrew 54 2004 Senior Vice President - Clinical Research and Development, Chief Medical Officer
Rabson, Michael 55 2008 Senior Vice President - Business Development & Legal Affair, General Counsel
Blum, Robert 45 2007 President, Chief Executive Officer, Director
Dow, Stephen 53 2009 Lead Outside Director
Morgans, David 56 2008 Executive Vice President - Preclinical Research and Development
Heidrich, A. Grant 56 1998 Director
Schmertzler, Michael 57 2003 Director
Spudich, James 67 1997 Director
Gilbert, Denise 51 2008 Director
Henderson, John 65 2009 Director
Gage, L. Patrick -- 2009 Director
Barbari, Sharon 54 2009 Chief Financial Officer, Executive Vice President - Finance
Sabry, James 50 2008 Chairman of the Board